Jakse G, Hofstädter F
Helv Chir Acta. 1978 Jul;45(3):313-6.
30 patients with papillary transitional bladder tumours were treated by TUR. The stage O and A tumour specimens obtained were examined for presence or loss of antigenicity by the specific red cell adherence test (SRCA). The patients were followed up between 4 and 17 years. A correlation between loss of antigenicity and secondary occurrence of tumours with more aggressive biological behaviour was apparent. Possible therapeutic consequences are discussed.
30例乳头状移行性膀胱肿瘤患者接受了经尿道切除术（TUR）。通过特异性红细胞黏附试验（SRCA）对所获得的0期和A期肿瘤标本进行抗原性存在或缺失的检测。对这些患者进行了4至17年的随访。抗原性缺失与具有更具侵袭性生物学行为的肿瘤二次发生之间的相关性明显。文中讨论了可能的治疗后果。
